Long term efficacy of DOTS regimens for tuberculosis: systematic review.
about
Interventions to improve safe and effective medicines use by consumers: an overview of systematic reviewsPersisting positron emission tomography lesion activity and Mycobacterium tuberculosis mRNA after tuberculosis cureFollow-up of patients with multidrug resistant tuberculosis four years after standardized first-line drug treatmentEffect of duration and intermittency of rifampin on tuberculosis treatment outcomes: a systematic review and meta-analysisPredictors of death among patients who completed tuberculosis treatment: a population-based cohort studyResearch questions and priorities for tuberculosis: a survey of published systematic reviews and meta-analysesTuberculosis recurrence in smear-positive patients cured under DOTS in southern Ethiopia: retrospective cohort studyThe Phytochemical Bergenin Enhances T Helper 1 Responses and Anti-Mycobacterial Immunity by Activating the MAP Kinase Pathway in MacrophagesThe experience of "medicine companions" to support adherence to antiretroviral therapy: quantitative and qualitative data from a trial population in UgandaTuberculosis (HIV-negative people).Nanoparticle-Formulated Curcumin Prevents Posttherapeutic Disease Reactivation and Reinfection with Mycobacterium tuberculosis following Isoniazid Therapy.Chronic airflow obstruction after successful treatment of multidrug-resistant tuberculosisRNTCP and tuberculosis control - High time to act.A meta-analysis of self-administered vs directly observed therapy effect on microbiologic failure, relapse, and acquired drug resistance in tuberculosis patientsImpact of community tracer teams on treatment outcomes among tuberculosis patients in South AfricaEffects of dosage, comorbidities, and food on isoniazid pharmacokinetics in Peruvian tuberculosis patientsImmunotherapeutic role of Ag85B as an adjunct to antituberculous chemotherapyAdherence in the treatment of patients with extensively drug-resistant tuberculosis and HIV in South Africa: a prospective cohort study.Associated factors for tuberculosis recurrence in Taiwan: a nationwide nested case-control study from 1998 to 2010.Characterization and evaluation of the directly observed treatment for tuberculosis in Santiago de Compostela (1996-2006)Tuberculosis (HIV-negative people): improving adherence.A sterilizing tuberculosis treatment regimen is associated with faster clearance of bacteria in cavitary lesions in marmosetsDesign, Synthesis, and Antimycobacterial Activity of Novel Theophylline-7-Acetic Acid Derivatives With Amino Acid Moieties.Efficacy of directly observed treatment short-course intermittent regimen in spinal tuberculosis.DOTS for TB relapse in India: A systematic review.Smoking increases the risk of relapse after successful tuberculosis treatment.Intracellular time course, pharmacokinetics, and biodistribution of isoniazid and rifabutin following pulmonary delivery of inhalable microparticles to mice.Managing TB in the 21st century: existing and novel drug therapies.The lack of a big picture in tuberculosis: the clinical point of view, the problems of experimental modeling and immunomodulation. The factors we should consider when designing novel treatment strategies.Comprehensive structural and functional characterization of Mycobacterium tuberculosis UDP-NAG enolpyruvyl transferase (Mtb-MurA) and prediction of its accurate binding affinities with inhibitors.Prison health advocacy and its changing boundaries.Intermittent Directly Observed Therapy for Abdominal Tuberculosis: A Multicenter Randomized Controlled Trial Comparing 6 Months Versus 9 Months of Therapy.Isoniazid induces apoptosis of activated CD4+ T cells: implications for post-therapy tuberculosis reactivation and reinfection.Host transcriptional responses following ex vivo re-challenge with Mycobacterium tuberculosis vary with disease status.Doubts about DOTS.Caveat emptor? Meta-analysis of studies comparing self-observed therapy and directly observed therapy for tuberculosis.Recurrent tuberculosis in Finland 1995-2013: a clinical and epidemiological cohort study.Changing trends in childhood tuberculosis.A woman's lived experience with directly observed therapy for tuberculosis-a case study.A description of patients with recurrence of Pulmonary Tuberculosis in a Tuberculosis Hospital, Ermelo.
P2860
Q24197536-8B2A6169-4071-4224-948A-18C0D77C1CA4Q28391110-C155FB6C-71D3-4F37-B426-0EA8E7C56200Q28474035-938F59B2-A914-474E-966D-EB016A859841Q28476120-43F35467-8017-47AC-BE29-7FB71283518FQ28477263-166ACF5E-2DA9-4017-B590-7EF319B69FFAQ28481610-6BA077AF-AF2E-4A48-88FA-CB66425902E2Q33504883-8E2EA2E0-EC59-4D0C-8CFD-0DD2A5730032Q33619303-39EBE77C-3E1F-4B20-A19E-EF56D846364AQ33648147-673A77C3-D6AE-41F8-B843-C76D1C89BB64Q33843941-350390BC-6DCE-4C10-94C7-DCB653F599C3Q33854476-1E1F16F7-AD50-46E9-AB1F-49907AF9FA5CQ33897501-2CE45826-9DE8-437D-83AB-EEF4CAD609B8Q34159923-5671C239-4D80-4FEF-BA37-1081899B55FCQ34332805-C6A71B47-CA32-45D5-AA26-442FCBA2B7B2Q34370030-CE3D7EB7-28D5-4735-9B9F-09F071015C1CQ34597564-701EFA12-B6C2-4F37-93E8-8A2E6D27B3CAQ35124651-6B568315-B2D5-4E41-884E-422D5642F560Q35538913-7FBEE19C-9886-4BCF-9438-E63ED323270BQ35560817-5EF8BFB8-7A81-4869-961F-61BD27E36621Q35727622-8D3FAC9A-24C4-43FE-82F2-0CE122EDCF16Q35742061-71BCF866-9A38-4200-8880-74743B89C3A9Q35745991-D72E62B9-0025-41C5-93AF-66F3AF577D2CQ35821643-9871EE5E-0DC8-4A64-B2D9-DC4A87587428Q35841643-E90E721E-22E7-4D83-98F1-C64203C295C6Q35966723-BEAE3A56-51FD-49AE-A08A-8B09C01F5347Q36790024-E9363733-118B-40B5-A16E-12C2CE60940CQ36870723-0633EED3-D0B4-4E9A-B8C6-8777C46AEDDBQ37362655-6D96D5F2-5207-47FD-8574-B02D6604BEEBQ38193087-CEB0C59C-D726-4ED4-91E9-2A3EEEB5C521Q38420842-20E6BC4F-854F-42C7-84F7-38A8090BAD76Q39228438-2B819734-D4F2-45C2-A444-6074F9065096Q40944804-E76C9558-A28D-48BC-ACAF-E123439E0C48Q41747286-8D500DE5-F94B-4ECC-BDE8-68B995C215ECQ41991298-74D051D2-83C8-4BFB-AB00-B6467A26B091Q43063598-AB93DED0-6121-4466-ACC4-09960A8E22E6Q43235840-866B085A-E37A-44A3-85B5-4B83CAE46F5FQ47149166-57E34A1E-9A95-437A-834B-FFE3524A4882Q51156113-4518C603-753A-460A-B906-6AFD49A68E7DQ51378142-62F8BD00-FF12-451F-B95B-5F948F1D1153Q53932227-3C7AC996-B272-43A5-9E00-E139B7BF2E12
P2860
Long term efficacy of DOTS regimens for tuberculosis: systematic review.
description
2008 nî lūn-bûn
@nan
2008年の論文
@ja
2008年学术文章
@wuu
2008年学术文章
@zh-cn
2008年学术文章
@zh-hans
2008年学术文章
@zh-my
2008年学术文章
@zh-sg
2008年學術文章
@yue
2008年學術文章
@zh
2008年學術文章
@zh-hant
name
Long term efficacy of DOTS regimens for tuberculosis: systematic review.
@ast
Long term efficacy of DOTS regimens for tuberculosis: systematic review.
@en
type
label
Long term efficacy of DOTS regimens for tuberculosis: systematic review.
@ast
Long term efficacy of DOTS regimens for tuberculosis: systematic review.
@en
prefLabel
Long term efficacy of DOTS regimens for tuberculosis: systematic review.
@ast
Long term efficacy of DOTS regimens for tuberculosis: systematic review.
@en
P2860
P1433
P1476
Long term efficacy of DOTS regimens for tuberculosis: systematic review
@en
P2093
Martha Morrow
Peter W Deutschmann
P2860
P304
P356
10.1136/BMJ.39463.640787.BE
P407
P50
P577
2008-02-04T00:00:00Z